Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wibke Bechtel-Walz

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Cell and Tissue Research|March 14, 2017
Epigenetics of kidney diseaseNicola Wanner, Wibke Bechtel-Walz
Nephron|July 13, 2023
The Interplay of Autophagy and Oxidative Stress in the Kidney: What Do We Know?Haihua Guo, Wibke Bechtel-Walz
Cell and Tissue Research|May 13, 2014
Chromatin dynamics in kidney development and functionWibke Bechtel-Walz, Tobias B Huber
Deutsche Medizinische Wochenschrift (1946)|March 23, 2026
[Genetic kidney diseases]Wibke Bechtel-Walz, Athina Ganner, Tobias Hermle
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|August 21, 2018
Long-Term Therapeutic Plasma Exchange Therapy as Effective Approach to Refractory Primary Acquired Pregnancy-Related Thrombocytopenic PurpuraWibke Bechtel-Walz, Gerd Walz, Elke Neumann-Haefelin
Case Reports in Nephrology and Dialysis|October 27, 2021
Development of Nivolumab/Ipilimumab-Associated Autoimmune Nephritis during Steroid TherapyEllen Gebauer, Wibke Bechtel-Walz, Christoph Schell, et al.
Ebiomedicine|February 27, 2015
Induction of Tet3-dependent Epigenetic Remodeling by Low-dose Hydralazine Attenuates Progression of Chronic Kidney DiseaseBjörn Tampe, Desiree Tampe, Elisabeth M Zeisberg, et al.
Clinical Kidney Journal|July 11, 2024
Long-term outcomes of adults with FSGS in the German Chronic Kidney Disease cohortEleni Stamellou, Jennifer Nadal, Bruce Hendry, et al.
Antioxidants (Basel, Switzerland)|January 22, 2024
ADP-Ribosylation Factor-Interacting Protein 2 Acts as a Novel Regulator of Mitophagy and Autophagy in Podocytes in Diabetic NephropathyHaihua Guo, Manuel Rogg, Julia Keller, et al.
Clinical Kidney Journal|August 16, 2024
Long-term outcomes of patients with IgA nephropathy in the German CKD cohortEleni Stamellou, Jennifer Nadal, Bruce Hendry, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Cell and Tissue Research|March 14, 2017
Epigenetics of kidney diseaseNicola Wanner, Wibke Bechtel-Walz
Nephron|July 13, 2023
The Interplay of Autophagy and Oxidative Stress in the Kidney: What Do We Know?Haihua Guo, Wibke Bechtel-Walz
Cell and Tissue Research|May 13, 2014
Chromatin dynamics in kidney development and functionWibke Bechtel-Walz, Tobias B Huber
Deutsche Medizinische Wochenschrift (1946)|March 23, 2026
[Genetic kidney diseases]Wibke Bechtel-Walz, Athina Ganner, Tobias Hermle
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|August 21, 2018
Long-Term Therapeutic Plasma Exchange Therapy as Effective Approach to Refractory Primary Acquired Pregnancy-Related Thrombocytopenic PurpuraWibke Bechtel-Walz, Gerd Walz, Elke Neumann-Haefelin
Case Reports in Nephrology and Dialysis|October 27, 2021
Development of Nivolumab/Ipilimumab-Associated Autoimmune Nephritis during Steroid TherapyEllen Gebauer, Wibke Bechtel-Walz, Christoph Schell, et al.
Ebiomedicine|February 27, 2015
Induction of Tet3-dependent Epigenetic Remodeling by Low-dose Hydralazine Attenuates Progression of Chronic Kidney DiseaseBjörn Tampe, Desiree Tampe, Elisabeth M Zeisberg, et al.
Clinical Kidney Journal|July 11, 2024
Long-term outcomes of adults with FSGS in the German Chronic Kidney Disease cohortEleni Stamellou, Jennifer Nadal, Bruce Hendry, et al.
Antioxidants (Basel, Switzerland)|January 22, 2024
ADP-Ribosylation Factor-Interacting Protein 2 Acts as a Novel Regulator of Mitophagy and Autophagy in Podocytes in Diabetic NephropathyHaihua Guo, Manuel Rogg, Julia Keller, et al.
Clinical Kidney Journal|August 16, 2024
Long-term outcomes of patients with IgA nephropathy in the German CKD cohortEleni Stamellou, Jennifer Nadal, Bruce Hendry, et al.
Pageof 2